Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C3orf41 Inhibitors

C3orf41 inhibitors are a class of compounds that interact with the human protein encoded by the C3orf41 gene. This gene is known to be conserved across several species, suggesting that it plays an important role in fundamental biological processes. However, the precise function of the C3orf41 protein remains unclear, and it represents a less-characterized area of cellular biochemistry. The protein encoded by this gene is presumed to have a cellular function that could be pivotal to various molecular pathways. Inhibitors targeting C3orf41 are designed to bind to this protein and modulate its activity, providing insight into its function by observing the outcomes of its inhibition. The development of these inhibitors typically involves the use of high-throughput chemical screens to identify molecules that can specifically bind to C3orf41 and alter its biochemical activity.

The process of discovering C3orf41 inhibitors usually begins with the development of an assay system that can measure the activity of the C3orf41 protein in vitro. Once an assay has been established, large libraries of small molecules can be tested for their ability to affect the activity of C3orf41. Initial hits from these screens are then subjected to further validation to confirm their direct interaction with the protein. This validation often includes the use of biophysical techniques such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), or x-ray crystallography to demonstrate that these small molecules specifically bind to C3orf41. Subsequent studies typically focus on understanding the nature of the interaction at a molecular level, including the binding site on the protein, the affinity of the interaction, and the specificity of the inhibitor for C3orf41 as opposed to other proteins.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor that might affect kinase signaling pathways, potentially influencing the expression of other kinases.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

This compound is a p38 MAP kinase inhibitor and could disrupt downstream signaling pathways, potentially affecting kinase expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that may alter various signaling pathways, potentially impacting the expression of certain kinases.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is also a PI3K inhibitor and could affect kinase signaling pathways, influencing kinase expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

As an mTOR inhibitor, rapamycin can alter cell growth pathways and potentially impact the expression of various kinases.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a broad-spectrum tyrosine kinase inhibitor and could influence the expression of a wide range of kinases.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib targets certain tyrosine kinases and may disrupt related signaling pathways, potentially affecting kinase expression.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib is a kinase inhibitor that targets multiple receptors and might influence the expression of various kinases.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib is a receptor tyrosine kinase inhibitor and could possibly affect the expression levels of certain kinases.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Palbociclib inhibits CDK4/6 and might indirectly influence the expression of kinases through cell cycle regulation.